Company AB Science

AB

FR0010557264

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Annual profits - Rate of surprise

Sector Specialty & Advanced Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:35:14 2024-05-29 am EDT			5-day change	1st Jan Change
1.95 ^EUR	-1.12%		-7.80%	-45.15%

May. 30	Transcript : AB Science S.A. - Special Call
May. 29	AB Science: towards a negative opinion from the CHMP, listing suspended	CF

AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.

Number of employees: 89

EUR in Million	2022	Weight	2023	Weight	Delta
Protein Kinase Inhibitors 100.0 %	1	100.0 %	1	100.0 %	+1.25%

EUR in Million	2022	Weight	2023	Weight	Delta
France 100.0 %	1	100.0 %	1	100.0 %	+1.25%

Managers	Title	Age	Since
Alain Moussy CEO	Chief Executive Officer	-	01-07-10
Laurent Guy DFI	Director of Finance/CFO	-	01-12-31
Christian Fassotte CTO	Chief Tech/Sci/R&D Officer	-	18-03-31
Alexis Bernard PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Alain Moussy CEO	Chief Executive Officer	-	01-07-10
Patrick Moussy BRD	Director/Board Member	-	01-07-10
Cécile de Guillebon BRD	Director/Board Member	62	21-06-26
Catherine Johnston-Roussillon BRD	Director/Board Member	66	21-06-26
Guillemette Latscha BRD	Director/Board Member	-	21-06-26
Renaud Sassi BRD	Director/Board Member	-	21-06-26

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	51,111,703	32,744,501 ( 64.06 %)	0	64.06 %

Name	Equities	%	Valuation
Alain Moussy 37.12 %	19,331,068	37.12 %	40 M €
Allianz Global Investors GmbH (France) 0.2504 %	130,377	0.2504 %	267 380 €
Financière Arbevel SA 0.2483 %	129,300	0.2483 %	265 171 €
La Française Asset Management SAS 0.1498 %	78,000	0.1498 %	159 964 €
Degroof Petercam Asset Services SA 0.0768 %	40,000	0.0768 %	82 033 €
Banque Degroof Petercam Luxembourg SA 0.0768 %	40,000	0.0768 %	82 033 €
FINEXIS SA 0.0499 %	26,000	0.0499 %	53 321 €
La Mondiale SAM (Investment Portfolio) 0.0302 %	15,717	0.0302 %	32 233 €
Lyxor International Asset Management SAS 0.0267 %	13,892	0.0267 %	28 490 €
Degroof Petercam Gestion 0.0192 %	10,000	0.0192 %	20 508 €

AB Science SA

3, avenue George V

75008, Paris

+33 1 47 20 00 14

http://www.ab-science.com

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.95 EUR

Average target price

6.895 EUR

Spread / Average Target

+253.59%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
AB SCIENCE	-45.15%	110M
MERCK KGAA	+15.54%	78.51B
KYOWA KIRIN CO. LTD.	+12.05%	9B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+58.17%	4.96B
SK BIOPHARMACEUTICALS CO., LTD.	-14.94%	4.84B
YUHAN CORPORATION	-.--%	3.72B
INDIVIOR PLC	+21.94%	2.48B
BETTA PHARMACEUTICALS CO., LTD.	-26.63%	2.19B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+16.75%	2.12B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-37.97%	1.94B

Specialty & Advanced Pharmaceuticals